Does OLAPARIB Cause Acquired gene mutation? 38 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Acquired gene mutation have been filed in association with OLAPARIB (Lynparza). This represents 0.2% of all adverse event reports for OLAPARIB.
38
Reports of Acquired gene mutation with OLAPARIB
0.2%
of all OLAPARIB reports
10
Deaths
1
Hospitalizations
How Dangerous Is Acquired gene mutation From OLAPARIB?
Of the 38 reports, 10 (26.3%) resulted in death, 1 (2.6%) required hospitalization.
Is Acquired gene mutation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Acquired gene mutation?
OSIMERTINIB (474)
GEFITINIB (250)
LAMIVUDINE (157)
CYCLOPHOSPHAMIDE (151)
DOXORUBICIN (138)
VINCRISTINE (124)
RITUXIMAB (122)
PREDNISOLONE (120)
TENOFOVIR DISOPROXIL (80)
CARBOPLATIN (64)
Which OLAPARIB Alternatives Have Lower Acquired gene mutation Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL